S. Kavi
Priya, V. Thamizhiniyan, S.
Subramanian*
Department of
Biochemistry, University of Madras, Guindy campus,
Chennai – 600 025, Tamil Nadu, India.
ABSTRACT:
Ficus bengalensis (FB) (Moraceae) is
commonly known as Banyan tree has been traditionally known for their beneficial
pharmacological properties. In the absence of systemic studies in the
literature, the present study was aimed to evaluate the antidiabetic
potential of Ficus
bengalensis
fruit extract in alloxan-induced experimental
diabetes in rats. The altered levels of biochemical parameters such as blood
glucose, plasma insulin, haemoglobin, glycosylated haemoglobin,
glycogen content in liver and muscle tissues, protein, urea, creatinine, uric aicd, AST, ALT
and ALP in the diabetic rats were significantly reverted back to near basal
values by the administration of Ficus bengalensis
fruit extract for 30 days. The levels of lipid peroxides in the plasma and pancreatic
tissues of diabetic rats were elevated significantly and were normalized by the
administration of Ficus
bengalensis
fruit extract. The activities of pancreatic enzymic
antioxidants and the levels of plasma non-enzymic
antioxidants were markedly declined in the diabetic rats. Upon treatment with Ficus bengalensis fruit
extract to diabetic rats, these decreased antioxidant levels were significantly
improved. Further, the altered levels of lipid profile were significantly
improved upon treatment with fruit extract. The results of the study indicate
that Ficus bengalensis fruit
extract possesses antidiabetic activity and the
results are comparable with gliclazide, an oral
standard hypoglycemic drug. The phytochemicals
present in the Ficus
bengalensis
fruit may account for the observed pharmacological properties.
Keywords: Medicinal plant; Ficus bengalensis; antidiabetic;
antioxidant; alloxan.
INTRODUCTION:
Diabetes
mellitus is a metabolic disorder of multiple aetiology
characterised by chronic hyperglycaemia
with disturbances of carbohydrate, protein and fat metabolism resulting from
defects in insulin secretion, insulin action, or both. The clinical diagnosis
of diabetes is often indicated by the presence of symptoms such as polyuria, polydipsia, and
unexplained weight loss, and is confirmed by measurement of abnormal
hyperglycaemia.1 The number of people suffering from the disease
worldwide is increasing at an alarming rate with a projected 366 million
peoples likely to be diabetic by the year 2030 as against 191 million estimated
in 2000.2
Though diet and exercise are crucial in
managing diabetes, most of the patients require oral drugs, which help the body
use glucose and prevent or reduce hyperglycaemia.
Oral diabetes medications include Sulfonylureas, Biguanides, Meglitinides, Alpha-glucosidase inhibitors, Thiazolidinediones,
incretins, and DPP-4 inhibitors are currently used
for the treatment of diabetes. However, all these drugs elicit detrimental side
effects. Hence search for a novel drug with reduced side effects is needed
preferentially from plant origin continues to overcome this global epidemic.
In
the past decade there has been an exponential growth in the field of herbal
medicine and these drugs are gaining popularity both in developing and
developed countries because of their natural origin and less side effects. Many
traditional medicines in use are derived from medicinal plants, minerals and
organic matter.3 A number of medicinal plants, traditionally used
for over 1000 years named rasayana are present in
herbal preparations of Indian traditional health care systems.4
Traditional herbal medicines are naturally occurring; plant derived substances
with minimal or no industrial processing that have been used to treat illness
within local or regional healing practices. Traditional herbal medicines are
getting significant attention in global health debates.5
Ficus bengalensis (FB) (Moraceae)
is commonly known as Banyan tree or Vata or Vada treen in Ayurveda.
There are more than 800 species and 2000 varieties of Ficus
species, most of which are native to the old world tropics.6 It is
endemic to Bangladesh, India and Sri Lanka. It is also known as Bengal fig,
Indian fig and East Indian fig, Indian Banyan or simply Banyan (English), also borh, nyagrodha (Sansikrat), Bat, Bargad and Bar
(Hindi). The English name Banyan is given by the Britishers
to this tree because under the tree Banias that is, the
Hindu merchants used to assemble business. The triad Ganges, the Himalayas and
the Banyan tree symbolize the images of India, for this reason it is considered
as National Tree.
Various parts of Ficus bengalensis are known to possess various
pharmacological properties such as Anthelmintic activity, Anti-inflammatory activity, Antibacterial
activity, Immunomodulatory activity, Antistress and antiallergic
activity, Analgesic and antipyretic activity, Antidiarrhoeal
activity, Antiatherogenic activity, Wound healing
activity, and Growth promoting activity.7 Ficus
bengalensis is one of the common plants used in
Tribal Belts of Midnapur (West) District of Bengal,
for the treatment of diabetes. In the absence of systemic literature, the
present study was aimed to evaluate the antidiabetic,
antioxidant and antidyslipidemic activity of ethanolic extract of Ficus bengalensis fruits in alloxan induced diabetic rats.
MATERIALS AND METHODS:
Plant
material
Ficus bengalensis
fruits were collected from a botanical garden in Guindy,
Chennai, Tamilnadu, India. The plants were identified
and authenticated and a voucher specimen was deposited at the Department of
Biochemistry, University of Madras, Chennai.
Preparation
of plant extract
The Ficus bengalensis fruits
were dried at room temperature and powdered in an electrical grinder, which
was then stored in an airtight container at 5°C until further use. The powdered
root was delipidated with petroleum ether (60 - 80°C)
for overnight. It was then filtered and soxhalation
was performed with 95% Ethanol. Ethanol was evaporated in a rotary evaporator
at 40 - 50° C under reduced pressure.
Phytochemical screening
The ethanolic
extracts of Ficus bengalensis fruit
extract were subjected to preliminary
phytochemical screening of various plant constituents
(Harborne, 1998).
Experimental
animals
Male albino Wistar
rats (150-180 g) were purchased from TANUVAS, Madavaram,
Chennai. The rats were housed in polypropylene cages lined with husk and kept
in Animal house, Department of Biochemistry. It was renewed every 24 hours. The
rats were fed with commercial pelleted rats chow (VRK
Nutritional Solutions, Maharashtra, India) and had free access to water. The
experimental rats were maintained in a controlled environment (12:12 hours
light/dark cycle) and temperature (30 ± 2°C). The experiments were designed and
conducted in accordance with the ethical norms approved by Ministry of Social
Justices and Empowerment, Government of India and Institutional Animal Ethics
Committee Guidelines for the investigation of experimental pain in conscious
rats. The rats were acclimatized for one week before starting the experiments.
Induction
of experimental diabetes in rats
Rats were induced diabetes by single intraperitonial injection of alloxan
monohydrate dissolved in sterile normal saline at a dose 120 mg/Kg, after 18
hours fasting to induce hyperglycemia.8 After 1 hour alloxan administration, the animals were fed on standard
pellets and water ad libitum.
Rats were supplied with 5% glucose solution for 48 hours after alloxan injection in order to prevent severe hypoglycaemia. After 1 week time for the development and
aggravation of diabetes, the rats with moderate diabetes having persistant glycosuria and
hyperglycemia (Blood Glucose range of above 250 mg/dL)
were considered as diabetic rats and used for the experiment. The treatment was
started on the eighth day after alloxan injection and
this was considered as first day of treatment.
Experimental
design
The rats were grouped into 4 groups,
comprising of 6 rats in each group as follows:
Group
1: Control Rats (Water and
food ad libitum).
Group
2: Alloxan induced
diabetic Rats.
Group
3: Diabetic Rats treated
with Ficus bengalensis fruit extract (250 mg/Kg Body weight/day)
in aqueous solution orally for 30 days.
Group
4: Diabetic Rats treated
with gliclazide (5mg/Kg body weight/day) in aqueous
solution orally for 30 days.
During
the experimental period, body weight of the rats was determined at regular intervals.
At the end of the experimental period, the rats were fasted over night,
anaesthetized, and sacrificed by cervical decapitation. The blood was collected
with or without anticoagulant for plasma and serum separation respectively.
Blood
glucose level was estimated by the method of glucose oxidase/peroxidase as described by Trinder9; plasma
protein by Lowry’s et al.10; urea by Natelson
et al.11; hemoglobin and glycosylated hemoglobin by the
methods of Drabkin and Austin,12 and Nayak and Pattabiraman,13 respectively. Plasma
insulin was assayed by using ELISA kit for rats. The levels of creatinine14
and uric acid,15 and the activities of AST16, ALT17
and ALP18 in serum were also assayed.
Oral Glucose Tolerance Test (OGTT)
At the
end of the experimental period, fasting blood glucose was monitored after
overnight fasting of rats. Then rats were orally administered with glucose
solution (2 g/kg bw) and the levels of blood glucose
in all the group of rats at 30, 60, 90 and 120 minutes after glucose administration
was measured using Glucometer.
Assay of oxidative stress markers and
antioxidants in pancreas and plasma
The
pancreatic tissues were excised, rinsed in ice-cold saline and were homogenized
in Tris–HCl buffer (100 mM,
pH 7.4) at 4°C, in a Potter– Elvehjem homogenizer
with a Teflon pestle at 600 rpm for 3 min. The homogenate was then centrifuged
at 12,000g for 30 min at 4°C. The supernatant was collected and used for the
determination of lipid peroxides and enzymatic antioxidants. Lipid peroxides were
determined by the method of Ohkawa et al.19
Enzymatic antioxidants such as superoxide dismutase,20 catalase,21
and glutathione peroxidase22 in pancreatic supernatant were assayed.
Further, the levels of lipid peroxides, and the non-enzymatic antioxidants such
as vitamin C,23 vitamin E,24 ceruloplasmin25
and glutathione (GSH)26 in plasma were determined by the methods of Omaye et al.27; Desai28; Ravin29;
Sedlak and Lindsay,30 respectively.
Determination of Liver and muscle glycogen content
The level of glycogen content in liver and
muscle was estimated as described by Morales et al. (1973).31 Briefly, Glycogen was precipitated from
the alkali
extract of the tissues by adding 1:3 volume of 95% ethanol and a drop of 1 M
ammonium acetate and was kept in a boiling water bath for 5 min. After cooling,
the samples were shaken and placed in a freezer overnight. The precipitated
glycogen was then collected by centrifugation at 3,000g for 40 min. The
precipitate was dissolved in water, then precipitated with alcohol and
centrifuged again. The final precipitate was dissolved in water and heated for
5 min in a boiling water bath. Then the samples were cooled in an ice-bath, anthrone reagent was added and heated for 20 min in a
boiling water bath. Again the samples were cooled to room temperature and the
green colour developed was read at 640 nm in a
Shimadzu spectrophotometer. The levels of glycogen were expressed as mg of
glucose/g of wet liver tissue.
Assay of plasma lipid profile
Cholesterol
content was estimated by the method of Parekh and Jung. Triglyceride was
estimated by the method of Rice. HDL Cholesterol fraction was separated by the
precipitation techniques of Burstein and Scholnick
and the cholesterol content was determined.
RESULTS:
Table
1 shows the presence of different phytochemicals such
as alkaloids, flavanoids, glycosides, saponins, tannins, phytosterol, terpenoids, and phenols in the ethanolic extract of Ficus bengalensis fruit.
Table
1 Phytochemical
screening of F. bengalensis
fruit extract
|
Phytoconstituents |
Inference |
Alkaloids
|
+ |
|
Flavonoids |
+ |
Glycosides
|
+ |
|
Saponins |
+ |
|
Tannins |
+ |
|
Phytosterol |
+ |
|
Triterpenoids |
+ |
|
Anthraquinones |
- |
|
Phenols |
+ |
The changes of body weight in control and experimental
group of rats were presented in Table 2. Diabetic rats exhibited significant
reduction in body weight when compared to normal control rats. Whereas,
diabetic rats treated with Ficus bengalensis fruit extract as well as gliclazide showed significant body weight gain.
Table
2. Effect of F. bengalensis
fruit extract on changes in body
weight of experimental groups of rats after 30 days treatment.
|
Groups |
Body weight (g) |
|
|
Initial |
Final |
|
|
Control |
170.14 ± 3.74 |
218.72 ± 5.21 |
|
Diabetic |
172.32 ± 2.95 |
145.19 ± 7.35* |
|
Diabetic + F. bengalensis extract |
160.29 ± 3.15 |
181.56 ± 5.71@ |
|
Diabetic + gliclazide |
164.34 ± 4.12 |
185.16 ± 6.36@ |
Values are given as
mean ± SD for groups of six rats in each. Values are statistically significant
at p < 0.05. Statistical significance was compared within the groups as
follows: *compared with control, @ compared
with diabetic rats.
Graph 1 represents the levels of blood glucose
at different time intervals, after oral administration of glucose (2g/ kg) in
control and experimental rats. OGTT revealed that the blood glucose value in
control rats reach peak at 60 minutes after the oral glucose load and gradually
return backs to normal levels at the end of 120 minutes. In diabetic control
rats, the blood glucose concentration was significantly greater than the
control values at 30 min and peak 60 minutes, and the curve shift to the right
even over the next 60 minutes indicates impaired glucose tolerance. Treatment
with fruit extract showed definite lower peak blood glucose values at 60
minutes after glucose load and also a peak returns to the basal level at the
end of 120 minutes.
Graph 1. Effect of F. bengalensis fruit extract on the blood
glucose level in the experimental groups of rats receiving an oral glucose
load.
Table
3. Effect of F. bengalensis fruit extract on the levels of blood glucose, plasma
insulin, hemoglobin, glycosylated hemoglobin, and urine
sugar in the experimental groups of rats.
|
Groups |
Glucose (mg/dl) |
Insulin (µU/ml) |
Hemoglobin (g/dl) |
Glycosylated hemoglobin (%) |
Urine sugar |
|
Control |
98.59 ± 10.25 |
14.98 ± 2.65 |
14.75 ± 2.46 |
6.67 ± 1.62 |
Nil |
|
Diabetic |
300.78 ± 22.36* |
5.64 ± 1.02* |
9.18 ± 1.97* |
13.38 ± 2.79* |
+++ |
|
Diabetic + F. bengalensis extract
|
145.32 ± 12.44@ |
10.41 ± 2.35@ |
11.54 ± 2.59@ |
8.22 ± 1.91@ |
Nil |
|
Diabetic + gliclazide |
118.12 ± 16.17@ |
12.04 ± 1.98@ |
12.19 ± 2.14@ |
7.95 ± 2.04@ |
Nil |
Values are given as
mean ± SD for groups of six rats in each. Values are statistically significant
at p < 0.05. Statistical significance was compared within the groups as
follows: *compared with control, @ compared
with diabetic rats.
Table
4. Effect of F. bengalensis
fruit extract on the levels of
protein, urea, creatinine and uric acid in plasma of
experimental groups of rats.
|
Groups |
Protein (g/dl) |
Urea (mg/dl) |
Creatinine (mg/dl) |
Uric acid (mg/dl) |
|
Control |
8.42 ± 1.15 |
24.90 ± 1.95 |
1.15 ± 0.10 |
2.37 ± 0.92 |
|
Diabetic |
5.66 ± 0.92* |
46.52 ± 4.18* |
2.22 ± 0.22* |
5.35 ± 1.28* |
|
Diabetic + F. bengalensis extract |
6.98 ± 0.88@ |
34.06 ± 3.04@ |
1.52 ± 0.11@ |
3.24 ± 0.96@ |
|
Diabetic + gliclazide |
7.44 ± 0.77@ |
32.62 ± 2.48@ |
1.34 ± 0.10@ |
2.75 ± 1.02@ |
Values are given as mean ± SD for groups of
six rats in each. Values are statistically significant at p < 0.05.
Statistical significance was compared within the groups as follows: *compared with control, @ compared
with diabetic rats.
Table
5. Effect of F. bengalensis
fruit extract on the activity of AST, ALT and ALP in the serum of
experimental groups of rats.
|
Groups |
AST |
ALT |
ALP |
|
Control |
66.22 ± 6.54 |
19.26 ± 2.49 |
84.51 ± 10.26 |
|
Diabetic |
111.89 ± 14.98* |
48.18 ± 4.81* |
155.36 ± 18.24* |
|
Diabetic + F. bengalensis extract
|
91.17 ± 10.29@ |
23.82 ± 3.96@ |
99.90 ± 11.28@ |
|
Diabetic + gliclazide |
81.62 ± 8.41@ |
22.91 ± 2.98@ |
102.50 ± 12.81@ |
The enzyme activities are expressed as: AST
and ALT µmoles of pyruvate liberated /h/mg of
protein; ALP µmoles of phenol liberated/min/mg of protein. Values are given as
mean ± SD for groups of six rats in each. Values are statistically significant
at p < 0.05. Statistical significance was compared within the groups as
follows: *compared with control, @ compared
with diabetic rats.
Table 3 depicts the effect of Ficus bengalensis fruit
extract on the levels of blood glucose, plasma insulin, hemoglobin, glycosylated hemoglobin, and urine sugar in the
experimental groups of rats. The elevated levels of blood glucose, glycosylated hemoglobin in the diabetic group of rats were
significantly reverted by the administration of Ficus bengalensis fruit extract. Conversely,
the decreased levels of plasma insulin, hemoglobin in diabetic group of rats
were elevated by the administration of extract compared to normal rats. Urine
sugar which is present in the diabetic group of rats was absent in extract as
well as gliclazide treated diabetic group of rats.
The effect of oral administration of Ficus bengalensis fruit
extract on the levels of total protein, urea, uric acid and creatinine
are presented in Table 4.
Table6. Effect of F.
bengalensis fruit extract on the level of TBARS
in plasma and pancreas of experimental groups of rats.
|
Groups |
TBARS |
|
|
Plasma |
Pancreas |
|
|
Control |
4.37
± 0.69 |
40.41
± 4.85 |
|
Diabetic |
8.32
± 1.61* |
78.36
± 9.54* |
|
Diabetic
+ F. bengalensis extract |
5.45
± 1.16@ |
58.48
± 6.71@ |
|
Diabetic
+ gliclazide |
5.24
± 1.02@ |
55.45
± 7.13@ |
Units: mM/100 g in tissues; nM/ml in
plasma. Values are given as mean ±
SD for groups of six rats in each. Values are statistically significant at p
< 0.05. Statistical significance was compared within the groups as
follows: *compared with control, @ compared
with diabetic rats.
Table
7. Effect of F. bengalensis
fruit extract on the activity of SOD, Catalase
and GPx, in pancreas of experimental groups of rats.
|
Groups |
SOD |
Catalase |
GPx |
|
Control |
5.35 ± 1.25 |
15.32 ± 2.09 |
6.15 ± 1.02 |
|
Diabetic |
1.48 ± 0.41* |
5.93 ± 1.30* |
3.19 ± 0.32* |
|
Diabetic + F. bengalensis extract |
3.71 ± 0.82@ |
12.35 ± 1.77@ |
4.56 ± 0.65@ |
|
Diabetic + gliclazide |
3.89 ± 0.76@ |
13.02 ± 1.88@ |
5.30 ± 0.92@ |
Activity is expressed as: 50% of inhibition of
epinephrine autooxidation/min/mg of protein for SOD;
µmoles of hydrogen peroxide decomposed/min/mg of protein for catalase; µmoles of glutathione oxidized/min/mg of protein
for GPx. Values are given as mean ± SD for groups of
six rats in each. Values are statistically significant at p < 0.05.
Statistical significance was compared within the groups as follows: *compared with control, @ compared
with diabetic rats.
Table
8. Effect of F. bengalensis
fruit extract on the levels of vitamin C, vitamin E, ceruloplasmin
and GSH in plasma of experimental groups of rats.
|
Groups |
Vitamin C |
Vitamin E |
Ceruloplasmin |
GSH |
|
Control |
1.45 ± 0.15 |
0.69 ± 0.10 |
12.19 ± 1.62 |
31.74 ± 3.99 |
|
Diabetic |
0.51 ± 0.08* |
0.32 ± 0.14* |
5.16 ± 0.89* |
15.99 ± 2.45* |
|
Diabetic + F. bengalensis extract |
0.99 ± 0.07@ |
0.55 ± 0.08@ |
9.75 ± 1.46@ |
23.86 ± 2.87@ |
|
Diabetic + gliclazide |
1.05 ± 0.09@ |
0.59 ± 0.06@ |
10.21 ± 1.88@ |
26.15 ± 3.06@ |
Units: mg/dl. Values are given as mean ± SD for
groups of six rats in each. Values are statistically significant at p <
0.05. Statistical significance was compared within the groups as follows: *compared with control, @ compared
with diabetic rats.
Table
9. Effect of F. bengalensis
fruit extract on the levels of
liver and muscle glycogen content in the experimental groups of rats.
|
Groups |
Glycogen (mg glucose/g tissue) |
|
|
Liver |
Skeletal muscle |
|
|
Control |
40.60 ± 3.32 |
7.82 ± 0.81 |
|
Diabetic |
18.55 ± 2.21* |
3.77 ± 0.43* |
|
Diabetic + F. bengalensis extract |
32.74 ± 3.56@ |
5.41 ± 0.64@ |
|
Diabetic + gliclazide |
30.75 ± 2.75@ |
5.64 ± 0.72@ |
Values are given as mean ± SD for groups of
six rats in each. Values are statistically significant at p < 0.05. Statistical
significance was compared within the groups as follows: *compared with control, @ compared
with diabetic rats.
Table
10. Effect of F. bengalensis
fruit extract on the levels of
total cholesterol, triglycerides, LDL-cholesterol and HDL-cholesterol in the
plasma of experimental groups of rats.
|
Groups |
Total cholesterol |
Triglycerides |
LDL |
HDL |
|
Control |
86.61 ± 10.54 |
62.39 ± 9.66 |
51.21 ± 5.52 |
26.69 ± 2.08 |
|
Diabetic |
168.25 ± 19.75* |
150.87 ± 15.77* |
135.35 ± 9.41* |
14.54 ± 1.42* |
|
Diabetic + F. bengalensis extract |
106.75 ± 15.78@ |
89.14 ± 10.45@ |
75.79 ± 7.32@ |
22.13 ± 1.98@ |
|
Diabetic + gliclazide |
95.35 ± 12.52@ |
82.46 ± 8.39@ |
62.97 ± 6.59@ |
26. 51 ± 2.09@ |
Units: mg/dl. Values are given as mean ± SD for
groups of six rats in each. Values are statistically significant at p <
0.05. Statistical significance was compared within the groups as follows: *compared with control, @ compared
with diabetic rats.
The altered levels of these parameters were
reverted back to near normalcy upon the treatment with the fruit extract.
Table 5 depicts the level of activities of
serum enzymes such as AST, ALT and ALP in normal control and experimental group
of rats. The increased levels of these enzymes were reverted back to near
normalcy upon the treatment with the fruit extract.
The level of TBARS in plasma and pancreas of
control and experimental group of rats are presented in Table 6. Diabetic rats
showed marked increase in TBARS when compared with control rats. Upon treatment
of fruit extract as well as gliclazide to the
diabetic rats showed significant decrease in the levels of TBARS when compared
with diabetic rats.
Table 7 shows the levels of activities of antioxidant
enzymes such as SOD, Catalase, and glutathione peroxidase in pancreatic tissues of normal control and
experimental group of rats. A significant decrease in the level of antioxidant
enzymes was observed in alloxan induced diabetic
rats. Upon treatment with ethanolic extract of Ficus bengalensis fruit
as well as gliclazide to alloxan
induced diabetic rats restored the level of antioxidant enzymes to normal.
The levels of non enzymatic antioxidant such
as Vitamin E, Vitamin C, Ceruloplasmin and reduced
glutathione in plasma of control and experimental group of rats are shown in
Table 8. The diminished levels of non-enzymatic antioxidants in the diabetic
group of rats were significantly improved to near normal values by the oral
administration of Ficus bengalensis fruit
extract as well as gliclazide, after 30 days of
treatment.
Table 9 depicts the level of liver and
muscle glycogen content in control and experimental group of rats. The
significant decrease in liver and muscle glycogen content were observed in
diabetic rats when compared with normal control rats and the level was brought
back nearer to normal by oral administration of Ficus bengalensis fruit extract as well as gliclazide.
Table 10 depicts the levels of total
cholesterol, triglycerides and lipoproteins (LDL and HDL) cholesterol levels of
normal control and experimental group of rats. The elevated levels of total
cholesterol, triglycerides and LDL-cholesterol and reduced level of
HDL-cholesterol was observed in diabetic rats was restored back nearer to the
normal after oral administration of Ficus bengalensis fruit extract as well as gliclazide.
DISCUSSION:
Induction of
diabetes with alloxan is associated with the
characteristic loss of body weight, which due to increased muscle wasting and
loss of tissue proteins.32 The diabetic control group exhibit
gradual weight loss as compared with the normal group. Diabetic rats treated
with Ficus bengalensis
extract as well as gliclazide for 30 days showed
a significant improvement in body weight as compared to diabetic animals, which
shows beneficial effects of the fruits extract. The capability of Ficus bengalensis
to protect body weight loss seems to be as a result of its ability to improve
glucose tolerance.
Alloxan induction
causes specific damage of β-cells and thus exerts a pronounced increase in
blood glucose concentration and decrease in plasma insulin levels. It is well
established that gliclazide is used as an antihyperglycemic drug, which increases the insulin
secretion from pancreas and it is often used as a standard drug in diabetic
models to compare the antidiabetic property of
various plant extracts. Oral administration of ficus
bengalensis fruits extract to alloxan-induced diabetic rats resulted in significant
reduction of blood glucose and increase of plasma insulin levels. This
indicates that the ficus bengalensis fruits
extract has antidiabetic activity by
potentiating the stimulation of insulin release from the remnant pancreatic
β-cells.
The
measurement of glycosylated haemoglobin
is one of the well established means to identify the average plasma glucose
concentration over prolonged periods of time, was first proposed by Koenig et al. (1976).33
In addition, HbA1c is an important marker in assessing a patient’s risk of
vascular complications. Due to persistent elevated blood glucose level under
diabetic condition, the circulating level of glycosylated
haemoglobin level increased.34 Hence,
measurement of both HbA1c and blood glucose levels are now used in the routine
management of diabetes.35 There was a significant elevation in the
levels of glycosylated haemoglobin,
in alloxan-induced diabetic rats compared to normal
control rats. Oral administration of Ficus bengalensis fruit extract brought back to near
normal as that of standard drug gliclazide treatment.
Liver plays
a unique role in regulating carbohydrate metabolism by maintaining glucose
concentrations in a normal range over both short and long periods of times. In
diabetes, alterations in hepatic glucose metabolism are observed, i.e.
increased post absorptive glucose production and impaired suppression of
glucose production together with diminished glucose uptake following
carbohydrate ingestion. The simultaneous overproduction of glucose and fatty
acids in liver further stimulates the secretion of insulin by the pancreatic
β-cells, and elicits further peripheral insulin resistance thereby
establishing a vicious circle.36 In the present study, a significant
decrease in liver and muscle glycogen content were observed in diabetic rats
when compared with normal control rats and the level was brought back nearer to
normal by oral administration of ficus bengalensis fruits extract as well as gliclazide indicating the improved glucose homeostasis.
Besides this Ficus bengalensis
fruits extract might involve in extra pancreatic action in alloxan-induced diabetic rats, by stimulating the
peripheral glucose utilization and or storage.
The
metabolism of proteins is abnormal in diabetes due to deficiency of insulin.37
Earlier studies indicate that serum protein and albumin levels were reduced in
diabetic rats.38 Total protein reduction may be due to increased
protein catabolism caused by impaired glucose homeostasis.39 A
significant decrease in the level of total protein was observed in serum of alloxan induced diabetic rats. This decreased level of
total protein were reverted back to near normal by Ficus
bengalensis fruit extract as well as gliclazide treated diabetic rats. This is possibly through
the increase of insulin secretion, thereby improvement in protein metabolism.
The levels
of urea, uric acid and creatinine which are markers
of renal dysfunction were found to be increased in the diabetic group of rats.40
After treatment with ethanolic extract, the levels of
these markers was significantly decreased which confirms the beneficial effect
of the fruit extract in diabetes associated renal complications.
The aminotransferases, AST and ALT are located in
liver cells and leak out and make their way into the general circulation when
liver cells are injured. The ALT is thought to be a more specific indicator of
liver inflammation, since the AST may be elevated in diseases of other organs
such as the heart or muscle. Alkaline phosphatases
act as marker of biliary function and cholestasis. The observed increase in the activities of
AST, ALT and ALP in the serum of diabetic rats might be mainly due to the
leakage of these enzymes from the liver cells into the blood stream.
On the other hand, treatment of the diabetic rats with Ficus bengalensis fruits extract caused reduction in the activity of these
enzymes indicating the non toxic as well as tissue protective role of the
extract.
Oxidative stress
definitely refers to the situation of imbalance between the levels of Reactive
oxygen species (ROS) and antioxidant defense. Protection of β-cells
against chronic hyperglycemia induced oxidative damage is an important target
for the treatment of type 2 diabetes.41 Diabetic rats showed
significant increased levels of oxidative stress marker, lipid peroxides in
pancreatic tissues and this is due to increased oxidative stress as a result of
persistent elevated supraphysiological glucose
concentration. The three major antioxidant enzymes, superoxide dismutase (SOD),
glutathione peroxidase (Gpx),
and catalase (CAT), differ from each other in
structure, tissue distribution, and cofactor requirement. These antioxidant
enzymes have got the ability to scavenge ROS relatively at low concentrations.
The activities of SOD and Catalase and GPx were lowered in the pancreatic tissue of diabetic rats.
Drugs with antioxidant properties were shown to protect pancreatic β-cells
against oxidative stress.42 Hence, Antioxidant treatment could be a potiential therapeutic procedure for diabetic
complications.43,44 Earlier reports indicate that oral
administration of Ficus bengalensis
fruits significantly increased the antioxidant enzymes activities.45
In the present study, oral administration of Ficus bengalensis fruits extract to diabetic rats restored the levels of lipid peroxides
in pancreatic tissues as well as in plasma and activities of the antioxidant
enzymes indicating the antioxidant nature of the fruits.
Apart from the
enzymic antioxidants, non-enzymic
antioxidants such as GSH, vitamin C, vitamin E and ceruloplasmin
play an excellent role in protecting tissues from oxidative threats. GSH is an
intra cellular thiol rich tripeptide,
which plays a major role in the protection of tissues.46 In the
present study, diabetic rats exhibited decreased level of GSH, which might be
due to increased utilization of GSH for scavenging free radicals by GPx. Vitamin C is a plasma hydrophilic antioxidant because
it disappears faster than other antioxidants when plasma is exposed to ROS.47
It functions as a free radical scavenger of active and stable oxyradicals. The observed decrease in plasma vitamin C in
diabetic rats might be due to increased utilization as an antioxidant defence against increased ROS or to a decrease in the GSH
level, since GSH is required for the recycling of vitamin C.48
Vitamin E is
a well known physiological antioxidant and membrane stabilizer. It interrupts
the chain reaction of lipid peroxy radicals, thus
protecting the cell structures against damage.49 The decreased level
of vitamin E observed in the diabetic rats is compatible with the hypothesis
that the plasma vitamin E plays a protective role against increased peroxidation in diabetes. The plasma ceruloplasmin
is a powerful free radical scavenger that oxidizes iron from the ferrous to
ferric state. Earlier reports suggest that ceruloplasmin
level decreases under diabetic conditions leading to the increased generation
of superoxide radicals and hydrogen peroxide. The observed decrease in plasma ceruloplasmin in diabetic rats may be due to increased
lipid peroxidation and, was reversed by treatment
with fruit extract. In the present study, it was found that the levels of non
enzymatic antioxidants such as Vitamin E, Vitamin C, ceruloplasmin
and reduced glutathione in plasma of alloxan induced
diabetic rats gets significantly decreased. Administration of Ficus bengalensis
extracts to diabetic rats resulted in a marked increase in the levels of these
non enzymatic antioxidants suggesting that the antioxidant potential of Ficus bengalensis fruit.
Dyslipidemia is
one of the major risk factors for cardiovascular disease in diabetes mellitus.
The characteristic features of diabetic dyslipidemia
include high plasma triglyceride concentration, low HDL cholesterol and
increased LDL-cholesterol concentrations.50 The altered lipid
profiles associated with diabetes mellitus are attributed to increased free
fatty acid flux secondary to insulin resistance. Type 2 diabetes is associated
with significant cardiovascular morbidity and mortality. Lowering of
cholesterol with statins reduces cardiovascular risk
in diabetes. But, most people with diabetes mellitus are often need treatment
with multiple agents to achieve therapeutic goals. Oral administration of Ficus bengalensis
fruit extract to diabetic rats significantly decrease the levels of
triglyceride, total cholesterol, LDL-cholesterol while at the same time
increase the HDL-cholesterol levels.
CONCLUSION:
The results of the present study indicate
that the Ficus bengalensis fruits
extract possess significant antidiabetic activity.
The observed pharmacological properties might be due to the presence of
biologically active ingredients present in Ficus bengalensis fruits. Also, the study provides a scientific
rationale for the use of Ficus bengalensis
fruits in the traditional medicine for the treatment of diabetes mellitus.
However, further studies to isolate the active principle responsible for the
observed pharmacological properties are warranted to explore the possible
mechanism by which the fruits extract aids in maintaining glucose and lipid
homeostasis.
REFERENCES:
1. American Diabetes
Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 35 (Suppl
1); 2012: S64-71.
2. Wild
SG, Roglic A, Green R and King H. Global prevalence
of diabetes. Estimated for the year 2000 and projection for 2030. Diabetes Care. 27; 2004: 1047-1054.
3. Grover
JK, Yadav S and Vats V. Medicinal plants of India
with hypoglycemic potentials. Journal of
Ethnopharmacology. 81; 2002: 81-100.
4. Scartezzini P, Sproni E. Review on some plants of Indian traditional
medicine with antioxidant activity. Journal of Ethnopharmacology.
71; 2000: 23–43.
5.
Tilburt JC, Kaptchuk TJ. Herbal
medicine research and global health: an ethical analysis. Bull
World Health Organ. 86 (8);
2008: 594-599.
6. Manoj A, Urmila A, Bhagyashri W, Meenakshi V, Akshaya W and Kishore NG. Anthelmintic activity
of Ficus
benghalensis. International journal of green pharmacy. 2 (3); 2008: 170-172.
7. Thakare VN, Suralkar AA, Deshpande
AD and Naik SR. Stem bark extraction of Ficus bengalensis Linn
for anti-inflammatory and analgesic activity in animal models. Indian
Journal of Experimental Biology. 48 (1); 2010: 39-45.
8.
Biswas TK and Mukherjee
B. Plant medicines of Indian origin for wound healing activity: a review. The
International Journal of Lower Extremity Wounds. 2 (1); 2003: 25-39.
9.
Harborne
JB. Phytochemical methods. A guide to modern techniques
of plant analysis. Chapman and Hall Int., New York, 1998; 3rd ed.
10.
Yamamoto H, Uchigata Y and Okamoto H. Streptozotocin and alloxan induce
DNA strand breaks and poly(ADP-ribose) synthetase in
pancreatic islets. Nature. 294
(5838); 1981: 284-286.
11. Trinder P.
Determination of glucose in blood using glucose oxidase
with an alternate oxygen acceptor. Annuals
of Clinical Biochemistry. 6; 1969: 24-27.
12. Lowry
OH, Rosebrough NJ, Farr AL and Randall RJ, Protein
measurement with the Folin phenol reagent. The Journal of Biological Chemistry.
193 (1); 1951: 265-275.
13. Natelson S,
Scott Ml and Beffa C. A rapid method for the
estimation of urea in biologic fluids. American
Journal of Clinical Pathology. 21 (3); 1951: 275-281.
14. Drabkin DL
and Austin JH. Spectrophotometric constants for common hemoglobin derivatives
in human, dog and rabbit blood. The
Journal of Biological Chemistry. 98; 1932: 719-733.
15. Nayak SS
and Pattabiraman TN. A new colorimetric method for
the estimation of glycosylated haemoglobin.
Clinica Chimica Acta. 109 (3); 1981: 267-274.
16. Brod J and
Sirota JH, The renal clearance of endogenous creatinine in man. The
Journal of Clinical Investigation. 27 (5); 1948: 645-654.
17. Caraway
WT. Determination of uric acid in serum by a carbonate method, American Journal of Clinical Pathology. 25 (7);
1955: 840-845.
18.
King J. The transaminases: alanine and aspartate transaminases. In: Practical clinical enzymology.
Van Nostrand Reinhold, London, (1965a); 199-208.
19.
King J. The hydrolases - acid and alakaline phosphatises. In: Practical
clinical enzymology. Van Nostrand
Reinhold, London, (1965b) 199-208.
20. Ohkawa H, Ohishi N and Vagi K. Assay for
lipid peroxides in animal tissues by thiobarbituric
acid reaction. Analytical Biochemistry.
95; 1979: 351-358.
21. Misra HP
and Fridrovich T. The role of superoxide anion in the
autoxidation of epinephrine and a simple assay for
superoxide dismutase. The Journal of
Biological Chemistry. 247; 1972: 3170-3175.
22. Takahara S,
Hamilton HB, Neel JV, Kobara TY et al, Hypocatalasemia: a new genetic carrier state. Journal of Clinical Investigation. 39;
1960: 610-619.
23. Rotruck JT,
Pope AL, Ganther HE, Swanson AB et al, Selenium:
biochemical role as a component of glutathione peroxidise.
Science. 179; 1973: 588-590.
24. Omaye ST,
Turnbull JD and Sauberlich HE. Selected methods for
the determination of ascorbic acid in animal cells, tissues, and fluids. Methods in Enzymology.
62; 1979: 3- 11.
25. Desai
JD In: Parker (ed), Methods in enzymology,
vol. 105, Academic Press, New York, 1984, pp.138.
26. Ravin
HA. An improved colorimetric enzymatic
assay of ceruloplasmin, The Journal of Laboratory and Clinical Medicine. 58; 1961: 161-168.
27. Sedlak J and
Lindsay RH, Estimation of total, protein-bound, and nonprotein
sulfhydryl groups in tissue with Ellman’s
reagent. Analytical Biochemistry.
25; 1968: 192–205.
28.
Morales
MA, Jabbagy AJ and Terenizi
HR. Mutations affecting accumulation of Neurospora
glycogen. News letter. 20; 1973:
24-25.
29. Parekh
AC and Jung DH. Cholesterol determination with ferric acetate-uranium acetate
and sulphuric acid ferrous sulphate
reagents. Analytical Chemistry. 42;
1970: 1423- 1427.
30. Rice
EW. In: Roedrick P and McDonal
RP, editors, Standard methods in clinical chemistry. Academic Press, New York,
1970, pp. 215.
31. Burstein
M, Scholnick HR and Morfin
R. Rapid method for the isolation of
lipoproteins from human serum by precipitation with polyanions,
The Journal of Lipid Research. 11;
1970: 583-595.
32. Swanston-Flatt SK, Day C,Bailey CJ and Flatt PR. Traditional plant treatment for diabetes: Studies
in normal and strptozotocin diabetic mice. Diabtologia. 33; 1990: 462-464.
33. Koenig RJ, Peterson CM, Jones RL, Saudek
C, Lehrman M and Cerami A.
Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. New England Journal of Medicine.
295(8); 1976: 417-420.
34. Larsen ML, Horder
M and Mogensen EF. Effect of long-term monitoring of glycosylated haemoglobin levels
in insulin-dependent diabetes mellitus. New England journal of Medicine. 323 (15); 1990: 1021-1025.
35.
American Diabetes Association. Diagnosis
and classification of diabetes mellitus. Diabetes
Care. 31; 2006: 55–60.
36. Postic C Dentin R, and Girard J. Role of
the liver in the control of carbohydrate and lipid homeostasis. Diabetes & Metabolism. 30 (5);
2004: 398-408.
37. Genuth M.
Plasma Insulin and glucose profile in normal, Obese and diabetic person.
Annals
of Internal Medicine. 79; 1973: 812-822.
38. Prakasam A,Sethupathy S and Pugalendi KV
(2004). Influence of Caseria esculenta root extractioin on
protin metabolism and marker nzymes
in streptozotocin induced diabetic rats. Polish Journal of Pharmacology. 56;
2004: 587-593.
39. Almadal TP and Vilstrup H. Strict insulin treatment
normalizes the organic nitrogen contents and the capacity of urea-nitrogen
synthesis in experimental diabetes in rats. Diabetologia. 31; 1988: 114-118.
40. Alarcon-Aguilar
FJ, Calzada-Bermejo F, Hernandez-Galicia E,
Ruiz-Angeles C and Roman-Ramos R. Acute and chronic hypoglycemic effect of Ibervillea sonorae root
extracts-II. Journal of Ethonopharmacology. 97; 2005: 447-452.
41. Marchetti P, Lupi R, Del Guerra S, Bugliani M,
Marselli L and Boggi U. The
beta-cell in human type 2 diabetes. Advances
in experimental medicine and biology. 654; 2010: 501-514.
42. Erejuwa OO, Sulaiman SA, Wahab
MS, Sirajudeen KN, Salleh
MS and Gurtu S. Antioxidant protection of Malaysian tualang honey in pancreas of normal and streptozotocin-induced
diabetic rats. Ann Endocrinol (Paris). 71 (4);
2010: 291-296.
43. Browlee M.
Biochemistry and molecular cell biology of diabetic complications. Nature. 414; 2001: 813-820.
44. Ha H
and Kim KH. Pathogenesis of diabetic nephropathy: The role of oxidative stress
and protein kinase C. Diabetes research and Clinical Practice. 45; 1999: 147-151.
45. Sugiura M,
Ohshima M, Ogawa K, and Yano M. Chronic administration of Satsuma mandarian fruit (Citrus unshi
MARC.). Improves oxidative stress in STZ induced diabetic rat liver. Biological & Pharmaceutical Bulletin.
29; 2006: 588-591.
46. Yoshida
K, Hirokawa J, Tagami S,
Kawakami Y, Urata Y and Kondo T. Weakened cellular
scavenging activity against oxidative stress in diabetes mellitus: regulation
of glutathione synthesis and efflux. Diabetologia. 38; 1995: 201-210.
47. Frei B,
England L, Ames BN. Ascorbate is an outstanding
antioxidant in human blood plasma. Proceedings
of the National Academy of Sciences of the United States of America 86;
1989: 6377-6381
48. Wefers H and
Sies H. The protection by ascorbate
and glutathione against microsomal lipid peroxidation is dependent on vitamin E. European Journal of Biochemistry. 174; 1988: 353-357
49.
Winklhofer-Roob BM,
Rock E, Ribalta J, Shmerling
DH and Roob JM. Effects of vitamin E and carotenoid status on oxidative stress in health and
disease. Evidence obtained from human intervention studies. Molecular Aspects of Medicine. 24 (6);
2003: 391-402.
50.
Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nature Clinical Practice. Endocrinology
& Metabolism. 5 (3); 2009: 150-159.
Received on 02.01.2013
Modified on 15.01.2013
Accepted on 20.01.2013
© A&V Publication all right
reserved
Research J. Pharmacology and
Pharmacodynamics. 5(2): March –April 2013, 110-118